Antinuclear Antibody (ANA)
Antinuclear antibodies (ANA) are a group of autoantibodies that target components within the cell nucleus, often associated with autoimmune conditions.
ANA is a screening biomarker for autoimmune diseases, especially systemic lupus erythematosus (SLE).
Key facts at a glance
- Units
- titer
- Clinical utility
- screening
- Result kind
- qualitative
- FDA-cleared
- Roche ANA, Abbott ANA, Siemens ANA, Inova ANA, Zeus ANA
Antinuclear antibodies (ANA) are a diverse group of autoantibodies that target various nuclear antigens, such as DNA, histones, and ribonucleoproteins. Their presence is a hallmark of several autoimmune diseases.
The ANA test is commonly used as a first-line screening tool for conditions like systemic lupus erythematosus (SLE), Sjögren's syndrome, and mixed connective tissue disease. A positive result indicates the need for further diagnostic evaluation.
ANA titers are reported as the highest dilution at which fluorescence is still visible. Titers of 1:80 or higher are generally considered positive, but clinical correlation is essential for accurate diagnosis.
Frequently asked questions
What does a positive ANA test mean?
Can a healthy person have a positive ANA test?
Sources
- 1
- 2Mayo Clinic: ANA TestSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy